Mechanistically, CML cells treated with gallic acid exhibited the disruption of multiple oncogenic pathways including ERK/MAPK, FLT3 and JAK/STAT, as well as impaired mitochondrial respiration. This evidence concerns the gene FLT3 and chronic myelogenous leukemia, BCR-ABL1 positive.